Reply: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection?
Hepatology
.
2023 Oct 1;78(4):E78-E79.
doi: 10.1097/HEP.0000000000000536.
Epub 2023 Jul 17.
Authors
Jin Ge
1
,
Jean C Digitale
2
,
Mark J Pletcher
2
3
,
Jennifer C Lai
1
Affiliations
1
Department of Medicine, Division of Gastroenterology and Hepatology, University of California, San Francisco, San Francisco, California, USA.
2
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
3
Department of Medicine, Division of General Internal Medicine, University of California, San Francisco, San Francisco, California, USA.
PMID:
37459558
DOI:
10.1097/HEP.0000000000000536
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Viral
COVID-19*
Humans
SARS-CoV-2
Vaccination
Substances
Antibodies, Viral